Bisphosphonate compliance in Japan from the perspective of product, formulation, and patient characteristics: analysis of medical insurance claim data

Abstract Background Bisphosphonates are the mainstay drugs for osteoporosis, but in clinical practice, they are often ineffective due to low compliance. However, there have been few studies examining compliance on a product-by-product basis or in detail in Japan. This study aimed to clarify the bisp...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenji Kabeya, Hiroki Satoh, Natsuyo Yanagi, Yasufumi Sawada
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Online Access:https://doi.org/10.1186/s40780-025-00434-5
Tags: Add Tag
No Tags, Be the first to tag this record!